Man Group plc Takes $3.53 Million Position in Alignment Healthcare, Inc. $ALHC

Man Group plc bought a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 148,159 shares of the company’s stock, valued at approximately $3,528,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Summit Securities Group LLC purchased a new position in Alignment Healthcare in the fourth quarter valued at approximately $26,000. Versant Capital Management Inc grew its stake in Alignment Healthcare by 463.3% during the second quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock worth $33,000 after buying an additional 1,135 shares during the period. Parallel Advisors LLC increased its position in shares of Alignment Healthcare by 87.7% in the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after acquiring an additional 773 shares in the last quarter. Larson Financial Group LLC acquired a new stake in shares of Alignment Healthcare in the third quarter worth $33,000. Finally, Signature Equity Partners LLC acquired a new stake in shares of Alignment Healthcare in the first quarter worth $46,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $13.40 on Tuesday. Alignment Healthcare, Inc. has a 12-month low of $12.70 and a 12-month high of $25.12. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. The company has a market capitalization of $2.78 billion, a price-to-earnings ratio of 70.53 and a beta of 1.10. The firm’s fifty day moving average price is $17.93 and its 200 day moving average price is $18.47.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The company had revenue of $1.34 billion during the quarter, compared to analysts’ expectations of $1.31 billion. During the same period in the prior year, the company posted $0.07 EPS. The firm’s revenue for the quarter was up 31.6% on a year-over-year basis. On average, research analysts forecast that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on ALHC shares. UBS Group restated a “neutral” rating on shares of Alignment Healthcare in a report on Wednesday, July 8th. Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Raymond James Financial lowered Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and cut their price objective for the company from $22.00 to $19.00 in a research report on Monday, August 3rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Alignment Healthcare in a research report on Tuesday, August 4th. Finally, Wall Street Zen downgraded Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Seven investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and an average target price of $23.60.

Insiders Place Their Bets

In other Alignment Healthcare news, EVP Joseph S. Konowiecki sold 25,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $24.00, for a total transaction of $600,000.00. Following the completion of the sale, the executive vice president owned 1,103,816 shares in the company, valued at $26,491,584. This trade represents a 2.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John E. Kao sold 298,000 shares of Alignment Healthcare stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $13.88, for a total value of $4,136,240.00. Following the sale, the chief executive officer owned 790,766 shares in the company, valued at $10,975,832.08. This represents a 27.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 1,009,951 shares of company stock worth $18,597,287. Company insiders own 5.20% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.